CNGA3 and achromatopsia: We demonstrate here that AAV5-CBA-mCnga3-mediated gene replacement therapy restored cone-specific ERG, cone-mediated visual acuity and visual contrast in the cpfl5 mouse, a naturally occurring mouse model of achromatopsia caused by Cnga3 deficiency.